Live webcast from the Erlangen University Hospital

SIEMENSA new, technologically innovative CT system, the SOMATOM Definition AS from Siemens Medical Solutions, is being put into operation for the first time worldwide in the surgical trauma center at the Erlangen University Hospital. Seriously injured patients can be comprehensively examined, and life-saving treatment is initiated faster than ever before.

The new emergency concept shows the enormous level of trust the hospital places in the strengths of the new Siemens scanner. With its SOMATOM Definition AS, Siemens has developed a CT system that adapts to all medical requirements, it adapts to any patient and to any clinical questions. This is the reason for the "AS" in its name: an abbreviation for Adaptive Scanner.

Regardless of the clinical question, whether children, obese patients, stroke, non-invasive cardiac imaging, emergency cases, or standard examinations - the new system turns highly complex examinations into an easy routine.

In addition, the SOMATOM Definition AS actively manages dose in 100% of all exams. Its Active Dose Shield dynamically removes clinically irrelevant dose for all exams and patients.

The adaptive system not only enables invaluable functional information of whole organs, to be measured, but also supports minimally invasive procedures such as the removal of tissue samples with three-dimensional images, providing the physician with precise orientation during the intervention.

Werner Bautz, M.D., Director of the Institute for Radiology and Medical Director of the University Hospital Erlangen, Michael Lell, M.D., and the physicians of the Institute for Radiology in cooperation with Siemens AG, would like to introduce you to the clinical benefits and technical basics of the new system.

The event will take place:
Monday, November 19, 2007
2:30 – 3:45 p.m. (MEZ)
8:30 - 9:45 a.m. (EST)
Erlangen University Hospital
Institute for Radiology
Ulmenweg 18, 91054 Erlangen

Login for the live webcast under:
http://www.uk-erlangen.de/DefinitionAS

About Siemens Medical Solutions
Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world’s largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics - such as Diagnostic Products Corporation and Bayer Diagnostics – mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30), according to U.S. GAAP. Further information can be found by visiting www.siemens.com/medical.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...